Farragher, Tracey M., Lunt, Mark, Plant, Darren, Bunn, Diane K., Barton, Anne and Symmons, Deborah P. M. (2010) Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies. Arthritis Care & Research, 62 (5). pp. 664-675. ISSN 2151-4658
Full text not available from this repository.Abstract
Objective To compare the clinical utility of anti–cyclic citrullinated peptide (anti-CCP) antibodies and rheumatoid factor (RF) testing in predicting both functional outcome and response to treatment in early inflammatory polyarthritis (IP) patients. Methods A total of 916 IP subjects from a primary care incidence registry (1990–1994) had anti-CCP antibody and RF status determined at baseline. Mean change in Health Assessment Questionnaire (HAQ) score between baseline and 5 years was compared by antibody status. The effect of treatment with disease-modifying antirheumatic drugs and/or steroids over 5 years, early (
Item Type: | Article |
---|---|
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Groups > Health Promotion Faculty of Social Sciences > Research Centres > Water Security Research Centre Faculty of Medicine and Health Sciences > Research Centres > Lifespan Health |
Depositing User: | Rhiannon Harvey |
Date Deposited: | 07 Mar 2012 11:57 |
Last Modified: | 19 Oct 2023 00:33 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/38005 |
DOI: | 10.1002/acr.20207 |
Actions (login required)
![]() |
View Item |